Abstract

Tet dioxygenases are responsible for the active DNA demethylation. The functions of Tet proteins in muscle regeneration have not been well characterized. Here we find that Tet2, but not Tet1 and Tet3, is specifically required for muscle regeneration in vivo. Loss of Tet2 leads to severe muscle regeneration defects. Further analysis indicates that Tet2 regulates myoblast differentiation and fusion. Tet2 activates transcription of the key differentiation modulator Myogenin (MyoG) by actively demethylating its enhancer region. Re-expressing of MyoG in Tet2 KO myoblasts rescues the differentiation and fusion defects. Further mechanistic analysis reveals that Tet2 enhances MyoD binding by demethylating the flanking CpG sites of E boxes to facilitate the recruitment of active histone modifications and increase chromatin accessibility and activate its transcription. These findings shed new lights on DNA methylation and pioneer transcription factor activity regulation.

Details

Title
Muscle regeneration controlled by a designated DNA dioxygenase
Author
Wang, Hongye 1 ; Huang Yile 2 ; Yu, Ming 3 ; Yang, Yu 1 ; Li, Sheng 4 ; Wang, Huating 5 ; Sun, Hao 5 ; Li, Bing 3   VIAFID ORCID Logo  ; Xu, Guoliang 6 ; Hu, Ping 7 

 Chinese Academy of Sciences, State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309) 
 The Chinese University of Hong Kong, Department of Chemical Pathology, Li Ka Shing Institute of Health Sciences, Hong Kong, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482) 
 Shanghai Jiao Tong University School of Medicine, Department of Biochemistry and Molecular Cell Biology, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
 Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China (GRID:grid.412987.1) (ISNI:0000 0004 0630 1330) 
 The Chinese University of Hong Kong, Department of Chemical Pathology, Li Ka Shing Institute of Health Sciences, Hong Kong, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482); Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Department of Orthopaedics and Traumatology, Hong Kong, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482) 
 Chinese Academy of Sciences, State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309); Medical College of Fudan University, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai, China (GRID:grid.11841.3d) (ISNI:0000 0004 0619 8943) 
 Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China (GRID:grid.412987.1) (ISNI:0000 0004 0630 1330); Max-Planck Center for Tissue Stem Cell Research and Regenerative Medicine, Bioland Laboratory (Guangzhou Regenerative Medicine and Health GuangdongLaboratory), Guangzhou, China (GRID:grid.412987.1); Chinese Academy of Sciences, Institute for Stem Cell and Regeneration, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309) 
Publication year
2021
Publication date
Jun 2021
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2531841061
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.